Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induced Pluripotent Stem (iPS) Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia

NCT02246491 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02246491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02246491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induced Pluripotent Stem (iPS) Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Terminated
Start date
February 3, 2015
Completion date
July 5, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia-telangiectasia (a-t)